The European Commission has announced a new, tougher policy on parallel
trade in the European pharmaceutical sector. Given the new Slovak
reference pricing legislation, pharmaceutical companies in Slovakia are likely to be affected.
European Commission revisits parallel trade in the pharma sector
Prepared by AmCham member: Allen & Overy Bratislava
The European Commission has announced a new, tougher policy on parallel trade in the European pharmaceutical sector. Given the new Slovak reference pricing legislation, pharmaceutical companies in Slovakia are likely to be affected.
Healthcare, IT& Telecoms
- New pharmaceutical industry rules
- Upgrading to Healthcare 2.0
- Deloitte´s Technology Fast 50
- How good is your design?
- Issues (not) addressed in the OPIS implementation
- Cloud computing – A new paradigm in data processing
- Flu can now be diagnosed through a PC
- To consent, or not to consent
- The future of IT outsourcing and cloud computing
- Focus on care pathway is the way to stabilize Slovak healthcare
- U. S. Steel´s Volunteer Days
- ICT services worldwide from Košice
- Geospatial revolution
- Clinical trials and the new law on medicines
- European Commission revisits parallel trade in the pharma sector
Follow us